| PVA Suspension from Official Quotation |
| 30/04/18 | PRICE SENSITIVE | 222.09KB | Share |
|
| PVA Reinstatement to Official Quotation |
| 26/04/18 | PRICE SENSITIVE | 221.52KB | Share |
|
| PVA Response to ASX Price and Volume Query |
| 26/04/18 | PRICE SENSITIVE | 985.68KB | Share |
|
| PVA Suspension from Official Quotation |
| 26/04/18 | PRICE SENSITIVE | 221.46KB | Share |
|
| PVA EyePoint Patent Allowance |
| 13/04/18 | PRICE SENSITIVE | 144.76KB | Share |
|
| PVA pSivida Announces Acquisition of Icon |
| 29/03/18 | PRICE SENSITIVE | 168.11KB | Share |
|
| PVA pSivida Announces FDA Acceptance For Filing of New Drug Appl |
| 20/03/18 | PRICE SENSITIVE | 66.22KB | Share |
|
| PVA pSivida Corp Dec 2017 Form 10-Q |
| 09/02/18 | PRICE SENSITIVE | 634.37KB | Share |
|
| PVA Form 8-K Earnings Release for Q2 FY 2018 |
| 09/02/18 | PRICE SENSITIVE | 72.28KB | Share |
|
| PVA pSivida Submits New Drug Application (NDA) for Durasert |
| 10/01/18 | PRICE SENSITIVE | 316.47KB | Share |
|
| PVA pSivida Granted Waiver by the FDA for NDA Fee |
| 05/01/18 | PRICE SENSITIVE | 245.5KB | Share |
|
| PVA HSS and pSivida Report Positive Phase 1 Knee Osteoarthritis |
| 15/12/17 | PRICE SENSITIVE | 526.78KB | Share |
|
| PVA Form 10-Q - September 30, 2017 |
| 14/11/17 | PRICE SENSITIVE | 173.5KB | Share |
|
| PVA Form 8-K (Q1 FY 2018 Earnings Release) |
| 08/11/17 | PRICE SENSITIVE | 70.92KB | Share |
|
| PVA pSivida and Nicox Enter Strategic Collaboration Agreement |
| 12/10/17 | PRICE SENSITIVE | 332.79KB | Share |
|
| PVA Prospectus Supplement |
| 21/09/17 | PRICE SENSITIVE | 39.96KB | Share |
|
| PVA pSivida Corp FY 2017 Form 10-K as filed for ASX |
| 14/09/17 | PRICE SENSITIVE | 1.14MB | Share |
|
| PVA Form 8-K Earnings Release |
| 13/09/17 | PRICE SENSITIVE | 72.43KB | Share |
|
| PVA EMEA Out License and Amended Global Collaboration Agreement |
| 11/07/17 | PRICE SENSITIVE | 66.75KB | Share |
|
| PVA Disclosure Document |
| 26/06/17 | PRICE SENSITIVE | 56.01KB | Share |
|
| PVA Disclosure Document |
| 16/06/17 | PRICE SENSITIVE | | Share |
|
| PVA Disclosure Document |
| 10/05/17 | PRICE SENSITIVE | 193.2KB | Share |
|
| PVA Disclosure Document |
| 09/05/17 | PRICE SENSITIVE | 381.8KB | Share |
|
| PVA Disclosure Document |
| 05/05/17 | PRICE SENSITIVE | 76.17KB | Share |
|
| PVA Abstract on pSivida's Treatment of Posterior Segment Uveitis |
| 16/03/17 | PRICE SENSITIVE | 528.59KB | Share |
|
| PVA Form 8K |
| 07/03/17 | PRICE SENSITIVE | 102.28KB | Share |
|
| PVA Disclosure Document |
| 09/02/17 | PRICE SENSITIVE | 349.17KB | Share |
|
| PVA Disclosure Document |
| 09/02/17 | PRICE SENSITIVE | 298.06KB | Share |
|
| PVA Disclosure Document |
| 08/02/17 | PRICE SENSITIVE | 189.32KB | Share |
|
| PVA Disclosure Document |
| 03/01/17 | PRICE SENSITIVE | 130.31KB | Share |
|
| PVA Disclosure Document |
| 09/11/16 | PRICE SENSITIVE | 131.53KB | Share |
|
| PVA pSivida Corp. Reports Fiscal 2017 First Quarter Results |
| 08/11/16 | PRICE SENSITIVE | 354.98KB | Share |
|
| PVA Disclosure Document-PSDV.O |
| 05/10/16 | PRICE SENSITIVE | 371.02KB | Share |
|
| PVA pSivida Reports Inducement Awards to New President and CEO-PSDV.O |
| 21/09/16 | PRICE SENSITIVE | 334.17KB | Share |
|
| PVA Nancy Lurker named president CEO of pSivida-PSDV.O |
| 16/09/16 | PRICE SENSITIVE | 347.75KB | Share |
|
| PVA pSivida 10K as filed with US SEC-PSDV.O |
| 14/09/16 | PRICE SENSITIVE | 743.06KB | Share |
|
| PVA pSivida provides company update and reports Q4 and FY 2016-PSDV.O |
| 13/09/16 | PRICE SENSITIVE | 266.24KB | Share |
|
| PVA pSivida announces 13 New patents issued or allowed-PSDV.O |
| 30/08/16 | PRICE SENSITIVE | 458.3KB | Share |
|
| PVA Primary Endpoint Met in pSivida's Utilization Study of Inser-PSDV.O |
| 10/08/16 | PRICE SENSITIVE | 448.43KB | Share |
|
| PVA pSivida & HSS announce opening of IND for OA-PSDV.O |
| 02/08/16 | PRICE SENSITIVE | 372.7KB | Share |
|
| PVA Medidur maintains same high statistical significance at 12 m-PSDV.O |
| 28/07/16 | PRICE SENSITIVE | 473.73KB | Share |
|
| PVA Announces Plan to Consolidate all R&D in current US Facility-PSDV.O |
| 18/07/16 | PRICE SENSITIVE | 344.09KB | Share |
|
| PVA Investigator-Sponsored P2 study results-PSDV.O |
| 15/07/16 | PRICE SENSITIVE | 467.66KB | Share |
|
| PVA pSivida announces preclinical data for TKIs in wet AMD-PSDV.O |
| 06/07/16 | PRICE SENSITIVE | 446.4KB | Share |
|
| PVA pSivida provides Co update and reports 3Q FY 16 results-PSDV.O |
| 06/05/16 | PRICE SENSITIVE | 243.58KB | Share |
|
| PVA Medidur for uveitis granted orphan drug designation in Europ-PSDV.O |
| 03/05/16 | PRICE SENSITIVE | 373.7KB | Share |
|
| PVA Additional Favorable 6-month safety results for Medidur |
| 16/03/16 | PRICE SENSITIVE | 235.62KB | Share |
|
| PVA Half Yearly Report and Accounts |
| 10/02/16 | PRICE SENSITIVE | 484.09KB | Share |
|
| PVA pSivida Corp. Provides Co Update and Reports Q2 FY 2016 resu |
| 09/02/16 | PRICE SENSITIVE | 244.74KB | Share |
|
| PVA pSivida Closes $17.8 Million Offering |
| 14/01/16 | PRICE SENSITIVE | 135.6KB | Share |
|
| PVA prospectus supplement as filed with US SEC |
| 11/01/16 | PRICE SENSITIVE | 163KB | Share |
|
| PVA pSivida announces pricing of $16 Million public offering of |
| 08/01/16 | PRICE SENSITIVE | 134.39KB | Share |
|
| PVA Trading Halt |
| 07/01/16 | PRICE SENSITIVE | 250.27KB | Share |
|
| PVA pSivida Announces Proposed Public Offering of Common Stock |
| 07/01/16 | PRICE SENSITIVE | 133.38KB | Share |
|
| PVA pSivida Plans to Apply for EU Approval with Single P3 Trial |
| 29/12/15 | PRICE SENSITIVE | 303.68KB | Share |
|
| PVA Medidur P3 Meets Primary Efficacy Endpoint |
| 23/12/15 | PRICE SENSITIVE | 323.87KB | Share |
|
| PVA S3 Registration statement filed with US SEC |
| 20/11/15 | PRICE SENSITIVE | 390.81KB | Share |
|
| PVA pSivida provides company update and reports first quarter re |
| 06/11/15 | PRICE SENSITIVE | 242.15KB | Share |
|
| PVA pSivida Medidur NDA to use 6 mo efficacy from both trials |
| 29/09/15 | PRICE SENSITIVE | 449.59KB | Share |
|
| PVA pSivida provides company update and reports Q4 and FY 2015 r |
| 10/09/15 | PRICE SENSITIVE | 248.12KB | Share |
|
| PVA pSivida announces positive top line results Phase II Medidur |
| 14/07/15 | PRICE SENSITIVE | 304.42KB | Share |
|
| PVA pSivida Reports Positive IOP Safety Data in Phase III Trial |
| 20/05/15 | PRICE SENSITIVE | 238.94KB | Share |
|
| PVA pSivida Announces Two Tech Evaluation Agreements |
| 13/05/15 | PRICE SENSITIVE | 91.01KB | Share |
|
| PVA pSivida reports third quarter FY 2015 results |
| 11/05/15 | PRICE SENSITIVE | 231.13KB | Share |
|
| PVA pSivida Reports Iluvien for DME Approved in Poland |
| 15/04/15 | PRICE SENSITIVE | 176.67KB | Share |
|
| PVA Completes Targeted Enrollment of Phase III Trial of Medidur |
| 27/03/15 | PRICE SENSITIVE | 183.14KB | Share |
|
| PVA Half Yearly Report and Accounts |
| 09/02/15 | PRICE SENSITIVE | 416.37KB | Share |
|
| PVA pSivida Corp. Reports Second Quarter FY 2015 Results |
| 06/02/15 | PRICE SENSITIVE | 168.62KB | Share |
|
| PVA pSivida Reports Iluvien Approved in Two More EU Countries |
| 27/01/15 | PRICE SENSITIVE | 214.95KB | Share |
|
| PVA pSivida Reports Commencement of Iluvien Sales in Portugal |
| 15/01/15 | PRICE SENSITIVE | 214.17KB | Share |
|
| PVA pSivida Reports Iluvien receives approval in Netherlands |
| 02/12/14 | PRICE SENSITIVE | 132.73KB | Share |
|
| PVA Reports Iluvien Granted Marketing Authorization in Ireland |
| 18/11/14 | PRICE SENSITIVE | 132.9KB | Share |
|
| PVA Iluvien granted marketing approval in Belgium |
| 13/11/14 | PRICE SENSITIVE | 92.93KB | Share |
|
| PVA pSivida Announces First Quarter Fiscal 2015 Results |
| 10/11/14 | PRICE SENSITIVE | 161.87KB | Share |
|
| PVA pSivida Receives $25 Million Milestone |
| 28/10/14 | PRICE SENSITIVE | 94.3KB | Share |
|
| PVA US FDA approves Iluvien for DME |
| 29/09/14 | PRICE SENSITIVE | 116.63KB | Share |
|
| PVA Results for Year Ended 30 June 2014 |
| 12/09/14 | PRICE SENSITIVE | 502.78KB | Share |
|
| PVA Fourth Quarter and FY 2014 Results |
| 10/09/14 | PRICE SENSITIVE | 165.71KB | Share |
|
| PVA ILUVIEN receives marketing authorization in Sweden |
| 04/09/14 | PRICE SENSITIVE | 94.14KB | Share |
|
| PVA ILUVIEN Receives Marketing Authorization in Denmark |
| 01/08/14 | PRICE SENSITIVE | 95.92KB | Share |
|
| PVA ILUVIEN Receives Marketing Authorization in Norway |
| 29/07/14 | PRICE SENSITIVE | 270.88KB | Share |
|
| PVA Reports Positive Regulatory Outcome for Iluvien |
| 01/07/14 | PRICE SENSITIVE | 98.8KB | Share |
|
| PVA Iluvien receives marketing authorisation in Italy |
| 24/06/14 | PRICE SENSITIVE | 269.92KB | Share |
|
| PVADisclosure Document |
| 14/05/14 | PRICE SENSITIVE | 171.97KB | Share |
|
| PVApSivida Reports Australia/New Zealand Distribution Agreement |
| 29/04/14 | PRICE SENSITIVE | 267.26KB | Share |
|
| PVApSivida announces resubmission of NDA for Iluvien |
| 28/03/14 | PRICE SENSITIVE | 171.32KB | Share |
|
| PVAProspectus Supplement |
| 18/03/14 | PRICE SENSITIVE | 171.32KB | Share |
|
| PVApSivida announces a US$7m investment by RA Capital |
| 14/03/14 | PRICE SENSITIVE | 173.52KB | Share |
|
| PVAForm 10-Q December 2013 |
| 13/02/14 | PRICE SENSITIVE | 433.53KB | Share |
|
| PVApSivida's Iluvien for DME accepted by NHS in Scotland |
| 11/02/14 | PRICE SENSITIVE | 172.13KB | Share |
|
| PVApSivida Corp. Reports Second Qtr 2014 Financial Results |
| 10/02/14 | PRICE SENSITIVE | 117.59KB | Share |
|
| PVAFirst orders for Iluven shipped to the UK for NHS hospitals |
| 14/01/14 | PRICE SENSITIVE | 187.24KB | Share |
|
| PVApSivida reports labeling discussions with FDA for Iluvien |
| 19/12/13 | PRICE SENSITIVE | 194.5KB | Share |
|
| PVApSivida reports that Iluvien to be funded by the UK's NHS |
| 03/12/13 | PRICE SENSITIVE | 222.06KB | Share |
|
| PVApSivida reports first quarter FY 2014 financial results |
| 13/11/13 | PRICE SENSITIVE | 165.62KB | Share |
|
| PVApSivida reports complete response letter from the FDA |
| 21/10/13 | PRICE SENSITIVE | 183.9KB | Share |
|
| PVATrading Halt |
| 18/10/13 | PRICE SENSITIVE | 100.23KB | Share |
|
| PVAUK's NICE recommends pSivida's Illuvien for reimbursement |
| 01/10/13 | PRICE SENSITIVE | 222.55KB | Share |
|
| PVAForm 10-K |
| 30/09/13 | PRICE SENSITIVE | 503.88KB | Share |
|
| PVApSivida reports fourth qtr and fiscal 2013 financial results |
| 26/09/13 | PRICE SENSITIVE | 235.89KB | Share |
|
